The Connection Between Oxidative Stress, Mitochondrial Dysfunction, Iron Metabolism and Microglia in Multiple Sclerosis: A Narrative Review
Authors:
- Simonida DelicSDSimonida Delic
- Svetlana Miletic DrakulicSDSvetlana Miletic Drakulic
- Milos StepovicMSMilos Stepovic
- Jovana MilosavljevicJMJovana Milosavljevic
- Marija Kovacevic DimitrijevicMDMarija Kovacevic Dimitrijevic
- Kristijan JovanovicKJKristijan Jovanovic
- Ivona MarinkovicIMIvona Marinkovic
- Melanija TepavcevicMTMelanija Tepavcevic
- Nikoleta JanicijevicNJNikoleta Janicijevic
- Aleksandra MitrovicAMAleksandra Mitrovic
- Danica IgrutinovicDIDanica Igrutinovic
- Maja VulovicMVMaja Vulovic
Open Access
Abstract
In recent years, in the pathogenesis of multiple sclerosis, emphasis has been placed on mitochondrial processes that influence the onset of the disease. Oxidative stress would be one of the consequences of mitochondrial dysfunction, and its impact on brain tissue is well described. Microglia, as a brain macrophage, have an important function in removing unwanted metabolites, as well as iron, which is an amplifier of oxidative stress. There are novelties in terms of the connection between these processes, which have redirected research more towards the process of neurodegeneration itself, so that the emphasis is no longer on neuroinflammation, which would initiate the pathological process itself and still exist in the vicinity of lesions with reduced intensity. The aim of this review is to summarize the current knowledge from the literature regarding oxidative stress, mitochondrial dysfunction and iron metabolism and how microglia are involved in these processes in multiple sclerosis.Keywords
Funding Information
- Faculty of Medical Sciences in Kragujevac, Republic of Serbia (JP 07/19)
This publication has 74 references indexed in Scilit:
- The interplay between mitochondrial dysfunction and NLRP3 inflammasome in multiple sclerosis: Therapeutic implications and animal model studiesBiomedicine & Pharmacotherapy, 2024
- Mitochondrial dysfunction in neurodegenerative disordersNeurotherapeutics, 2023
- Anti-inflammatory-antioxidant modifications and synbiotics improved health-related conditions in patients with progressive forms of multiple sclerosis: A single-center, randomized clinical trialComplementary Therapies in Clinical Practice, 2023
- Neurodegeneration in multiple sclerosisWIREs Mechanisms of Disease, 2022
- Microglia in multiple sclerosis: Protectors turn destroyersNeuron, 2022
- Blood biomarkers for assessment of mitochondrial dysfunction: An expert reviewMitochondrion, 2022
- Pathogenic mitochondrial dysfunction and metabolic abnormalitiesBiochemical Pharmacology, 2021
- A lymphocyte–microglia–astrocyte axis in chronic active multiple sclerosisNature, 2021
- Serum malondialdehyde as a lipid peroxidation marker in multiple sclerosis patients and its relation to disease characteristicsMultiple Sclerosis and Related Disorders, 2021
- Treatment of Multiple Sclerosis: A ReviewThe American Journal of Medicine, 2020